Iron Sucrose Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Iron Sucrose Injection (injection) from Mylan Institutional, A Viatris Company with status To Be Discontinued. The shortage was first posted on May 21, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Mylan Institutional, A Viatris Company
- Package NDC
- 67457-957-99
- Dosage Form
- Injection
- Presentation
- Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)
- Initial Posting
- May 21, 2026